Analogic Corporation Receives New Order for Its EXplosive Assessment Computed Tomography Systems

PEABODY, MASS. (September 26, 2006) – Analogic Corporation (NASDAQ: ALOG) announced today that the Company has received a new order for its EXplosive Assessment Computed Tomography (EXACT™) Systems from L-3 Communications’ (NYSE: LLL) subsidiary, L-3 Communications Security and Detection Systems, Inc. Under terms of the order, Analogic will ship units valued at a minimum of $31,000,000 and a maximum of $36,000,000 beginning in October 2006 and continuing through January 2008.

The EXACT is the heart of L-3’s eXaminer 3DX®, a certified Explosives Detection System (EDS) that has been installed at many major airports across the United States. Boston’s Logan International Airport, a world leader in aviation security, has 44 units. More than 650 systems are installed in airports around the world, including Israel’s new Ben Gurion terminal.

John Wood, Analogic President and CEO, said, “The recent terrorist threats in London reinforce the importance of having advanced screening systems in place for both checked and carry-on baggage. We expect that a number of units from this new L-3 order will be upgraded to our new AN6400, once the final field trials for Analogic’s new upgrade kit are completed at John Wayne Airport in Orange County, California. Those trials are scheduled to begin in October.” The U.S. Transportation Security Administration (TSA) certified the AN6400, a major system upgrade for existing EXACT systems, in May 2005. The upgraded system is marketed worldwide by L-3 as the eXaminer 3DX 6500D. Analogic’s upgrade kit was developed as part of the TSA’s Phoenix Category I Program, and includes a significant reduction in the false-alarm rate, increased throughput to 550 bags an hour, dual-energy detection capability, and an entirely new workstation with advanced 3-D threat-imaging software.

Analogic Corporation is a leading designer and manufacturer of advanced health and security systems and subsystems sold primarily to Original Equipment Manufacturers (OEMs). The Company is recognized worldwide for advancing the state of the art in Computed Tomography (CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging (MRI), and Patient Monitoring.

Forward-Looking Statements

Any statements in this press release about future expectations, plans, and prospects for the Company, including statements about orders for the Company’s products, statements about shipments and installation of the Company’s products, and other statements containing the words “believes,” “anticipates,” “plans,” “expects,” and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including risks relating to technology development and commercialization, risks in product development, limited demand for the Company’s products, risks associated with competition, uncertainties associated with regulatory agency approvals, competitive pricing pressures, downturns in the economy, the risk of potential intellectual property litigation, and other factors discussed in our most recent quarterly report filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Company’s views as of September 26, 2006. The Company anticipates that subsequent events and developments will cause the Company’s views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to September 26, 2006.